TELA Bio (NASDAQ:TELA) PT Lowered to $12.00 at Canaccord Genuity Group

TELA Bio (NASDAQ:TELA – Free Report) had its price target lowered by Canaccord Genuity Group from $14.00 to $12.00 in a report released on Tuesday, Benzinga reports. The firm currently has a buy rating on the stock. Separately, Piper Sandler reaffirmed an overweight rating and set a $10.00 price objective (down previously from $12.00) on […]

Leave a Reply

Your email address will not be published.

Previous post United Fire Group (NASDAQ:UFCS) Downgraded by StockNews.com
Next post Take-Two Interactive Software (NASDAQ:TTWO) Lifted to “Buy” at HSBC